The cancer therapeutics market size is expected to reach US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The market is estimated to record a CAGR of 12.8% from 2025 to 2031.

 

Executive Summary and Global Market Analysis

The global market for cancer treatments is showing a consistent positive growth trend. This is a direct consequence of the increasing global incidence of breast and lung cancer, alongside substantial financial commitments to cancer research. Treatment options are diverse, including chemotherapy, radiation therapy, immunotherapy, and targeted and hormone therapies. The core aims of all these treatments are to either cure the disease or improve patient outcomes, encompassing both survival rates and quality of life. Treatment plans are frequently customized, often involving a blend of various therapies, meticulously chosen based on the patient's specific cancer type, stage, and overall health status.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00031299

 

Cancer Therapeutics Market Segmentation Analysis

A clear segmentation of the market reveals three fundamental categories: therapy type, indication, and distribution channel. In terms of therapy types, chemotherapy was the largest segment in 2024, clearly demonstrating its market leadership. For indications, the lung cancer segment held the largest share, highlighting its dominance within the disease category. When examining distribution channels, hospital pharmacies were the leading channel, accounting for the biggest portion of the market. This concise breakdown offers an insightful snapshot of the market's structure and its key operational components.

 

Cancer Therapeutics Market Drivers and Opportunities

The increasing global disease burden is a primary driver for market growth. The World Health Organization (WHO) reports that approximately one in six deaths globally are due to cancer. In 2022, an estimated 20 million new cancer diagnoses occurred, with this number projected to increase dramatically by 77% by 2050, posing significant challenges for healthcare systems. Inherited genetic factors also play a role, with 5–10% of all cancers having a genetic link. Mutations in genes like BRCA1 and BRCA2 are specific examples contributing to the rising prevalence of breast cancer, which is further influenced by environmental and lifestyle factors.

 

Cancer Therapeutics Market Size and Share Analysis

When analyzing the market's size and share, the chemotherapy segment remains the largest in 2024. Its prominence is a result of its mechanism of action—traveling through the bloodstream to affect cancer cells throughout the body. The National Institutes of Health estimates that approximately 650,000 cancer patients in the US receive chemotherapy annually, underscoring its extensive and continued use. In terms of specific disease areas, the lung cancer segment held the largest share of the market in 2024, reflecting the significant and sustained demand for effective treatments for this widespread condition.

 

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications